CBL Semaglutide CBL Semaglutide

X

Find Radio Compass News for Semaglutide

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

left grey arrow
right gray arrow
  • SOLUTION;SUBCUTANEOUS - 2MG/3ML (0.68MG/ML)
  • SOLUTION;SUBCUTANEOUS - 2MG/1.5ML (1.34MG/ML)
  • SOLUTION;SUBCUTANEOUS - 4MG/3ML (1.34MG/ML)
  • SOLUTION;SUBCUTANEOUS - 8MG/3ML (2.68MG/ML)

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-sun-cipla-and-biocon-look-to-recreate-ozempic-magic-in-india/articleshow/109653300.cms

Teena Thacker ECONOMICTIMES
28 Apr 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/about-36-mln-medicare-beneficiaries-could-be-eligible-wegovy-coverage-study-2024-04-24/

REUTERS
25 Apr 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/indias-biocon-developing-its-own-version-wegovy-clinical-trial-likely-next-year-2024-04-18/

Rishika Sadam REUTERS
18 Apr 2024

https://economictimes.indiatimes.com/industry/healthcare/biotech/biocon-partners-biomm-to-commercialise-diabetes-drug-in-brazil/articleshow/109379384.cms

ECONOMICTIMES
17 Apr 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/eu-regulator-finds-no-link-between-weight-loss-drugs-suicidal-thoughts-2024-04-12/

Bhanvi Satija REUTERS
13 Apr 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/gerresheimer-supplies-key-players-glp-1-drugs-market-ceo-says-2024-04-11/

REUTERS
11 Apr 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/gerresheimer-expects-sales-boost-burgeoning-obesity-drugs-sector-2024-04-11/

Louis Van Boxel-Woolf REUTERS
11 Apr 2024

https://www.reuters.com/markets/deals/novo-nordisk-parent-refiles-us-application-catalent-deal-2024-04-08/

REUTERS
09 Apr 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-first-biosimilar-ozempic-drug-applies-approval-2024-04-03/

Andrew Silver REUTERS
04 Apr 2024

https://www.fiercepharma.com/pharma/eisai-biogens-injectable-leqembi-delayed-fda-asks-more-data

FIERCE PHARMA
02 Apr 2024

https://endpts.com/bernie-sanders-implores-novo-to-cut-list-prices-of-ozempic-wegovy/

Lia DeGroot ENDPTS
28 Mar 2024

https://www.theguardian.com/global-development/2024/mar/28/drug-companies-diabetes-drugs-medicines-ozempic-trulicity

Kat Lay THEGAURDIAN
28 Mar 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/novo-ready-seek-german-insurance-coverage-wegovy-heart-use-2024-03-25/

REUTERS
25 Mar 2024

https://www.fiercepharma.com/pharma/novo-nordisk-closes-eu-approval-its-once-weekly-insulin

FIERCE PHARMA
23 Mar 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-be-covered-by-us-medicare-heart-disease-patients-2024-03-21/

Ahmed Aboulenein REUTERS
22 Mar 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/germanys-health-insurance-could-cover-wegovy-strokes-heart-conditions-agency-2024-03-22/

Ludwig Burger REUTERS
22 Mar 2024

https://endpts.com/diabetes-and-weight-loss-drug-advertising-tops-1b-on-strength-of-glp-1-brand-spending/

Beth Snyder Bulik ENDPTS
21 Mar 2024

https://www.fiercepharma.com/pharma/riding-glp-1-wave-novo-nordisk-lays-out-560m-bolster-drug-production-china

Fraiser Kansteiner FIERCE PHARMA
19 Mar 2024

https://endpts.com/in-oprahs-tv-special-wegovy-and-zepbound-are-the-stars/

Beth Snyder Bulik ENDPTS
19 Mar 2024

https://www.accesswire.com/844289/canada-pharmacy-now-offers-wegovy-an-fda-approved-treatment-to-help-overweight-adults

ACCESSWIRE
18 Mar 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-weight-loss-drug-zepbound-new-us-prescriptions-surpass-wegovy-first-time-2024-03-15/

REUTERS
15 Mar 2024

https://endpts.com/cbo-hints-that-medicare-may-soon-cover-obesity-drugs-for-their-cardiovascular-benefits/

Zachary Brennan ENDPTS
12 Mar 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/compounded-semaglutide-poses-serious-us-health-issue-novo-nordisk-ceo-says-2024-03-08/

Patrick Wingrove REUTERS
09 Mar 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/fda-approves-novo-nordisks-wegovy-use-reducing-heart-attack-risks-2024-03-08/

Patrick Wingrove REUTERS
09 Mar 2024

https://www.biopharmadive.com/news/novo-nordisk-obesity-pill-amycretin-wegovy/709608/

Jonathan Gardner BIOPHARMADIVE
08 Mar 2024

https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=167028

PRESS RELEASE
06 Mar 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/semaglutide-reduces-severity-type-liver-disease-people-with-hiv-study-shows-2024-03-05/

REUTERS
06 Mar 2024

https://www.globenewswire.com//news-release/2024/03/05/2840807/0/en/ACTG-CROI-Presentations-Show-That-Semaglutide-Improves-Metabolic-Associated-Steatotic-Liver-Disease-Among-People-Living-With-HIV.html

GLOBENEWSWIRE
05 Mar 2024

https://endpts.com/from-nikkei-biotech-novo-nordisk-launches-obesity-treatment-wegovy-in-japan/

ENDPTS
01 Mar 2024

https://endpts.com/novo-plans-for-life-after-wegovy-setting-up-roots-in-boston-to-try-and-find-its-future/

ENDPTS
28 Feb 2024

https://endpts.com/fda-goes-after-websites-marketing-unapproved-semaglutide-tirzepatide/

Nicole DeFeudis ENDPTS
15 Feb 2024

https://endpts.com/fda-commissioner-hints-at-cardio-related-label-expansion-for-wegovy-full-approval-for-lillys-new-alzheimers-drug/

Zachary Brennan ENDPTS
15 Feb 2024

https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/fda-warns-online-vendors-selling-misbranded-weight-loss-diabetes-drugs/107680280#:~:text=New%20Delhi%3A%20The%20U.S.%20Food,diabetes%20and%20weight%2Dloss%20drugs.

HEALTH ET
14 Feb 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/weight-loss-drugs-tied-benefit-after-hip-replacement-2024-02-12/

REUTERS
12 Feb 2024

https://www.fiercepharma.com/pharma/novo-nordisk-settles-2-florida-sellers-compounded-ozempic

FIERCE PHARMA
10 Feb 2024

https://www.reuters.com/markets/deals/novo-holdings-buy-catalent-115-billion-expand-wegovy-capacity-2024-02-05/

REUTERS
06 Feb 2024

https://www.fiercepharma.com/pharma/novo-nordisk-doubles-stock-wegovy-starter-doses-supply-constraints-persist-ceo

FIERCE PHARMA
01 Feb 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/rise-reports-fake-weight-loss-drugs-linked-shortage-real-thing-who-says-2024-01-29/

Patrick Wingrove REUTERS
30 Jan 2024

https://www.prnewswire.com/news-releases/orderlymeds-unveils-innovative-injectable-and-oral-semaglutide-for-breakthrough-weight-loss-management-in-atlanta-302048144.html

PR NEWSWIRE
30 Jan 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/suspected-fake-ozempic-linked-three-us-cases-hypoglycemia-2024-01-24/

REUTERS
25 Jan 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-does-not-refer-wegovy-notes-after-this-weeks-review-2024-01-26/

REUTERS
25 Jan 2024

https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/eu-drug-watchdog-to-consider-wider-use-of-wegovy-weight-loss-drug/107055665

HEALTH ET
23 Jan 2024

https://www.fiercebiotech.com/biotech/novo-holdings-plans-ramp-dealmaking-amid-wegovy-windfall

Nick Paul Taylor FIERCE BIOTECH
19 Jan 2024

https://endpts.com/novo-nordisk-restarts-advertising-for-obesity-drug-wegovy-with-new-campaign/

ENDPTS
16 Jan 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-says-no-evidence-yet-linking-weight-loss-drugs-suicidal-thoughts-2024-01-11/

REUTERS
12 Jan 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/novo-ceo-expects-patients-stay-wegovy-longer-than-older-weight-loss-drugs-2024-01-09/

REUTERS
10 Jan 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-ozempic-not-linked-increase-suicidal-thoughts-us-study-finds-2024-01-05/

REUTERS
06 Jan 2024

https://www.ft.com/content/ee322048-a7f1-4762-8533-a700262c8409

FINANCIAL TIMES
05 Jan 2024

https://www.luxtimes.lu/luxembourg/obesity-drug-maker-to-build-mega-factory-to-meet-demand/5976648.html

LUXTIMES
25 Dec 2023

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-warns-about-counterfeit-versions-novos-diabetes-drug-ozempic-2023-12-21/

REUTERS
22 Dec 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY